Rhythm Pharmaceuticals (RYTM) Debt Ratio (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) has 6 years of Debt Ratio data on file, last reported at 0.25 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 13.42% year-over-year to 0.25 in Q1 2026; TTM through Mar 2026 was 0.25, a 13.42% decrease from a year earlier, with the FY2025 full-year figure at 0.23, down 19.52% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.25, up from 0.23 in the prior quarter.
• Over the last five years, Debt Ratio for RYTM reached as high as 0.32 in Q4 2023 and fell as low as 0.12 in Q2 2022.
• Historically, Debt Ratio has averaged 0.24 across 5 years, with a median of 0.25 in 2026.
• Across the five-year window, Debt Ratio slipped 12.24% in 2024 and slipped 19.52% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.19 in 2022, then surged by 70.34% to 0.32 in 2023, then slipped by 12.24% to 0.28 in 2024, then slipped by 19.52% to 0.23 in 2025, then grew by 8.85% to 0.25 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.25 in Q1 2026, 0.23 in Q4 2025, and 0.21 in Q3 2025.